Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:2056-2064
Published online before print October 23, 2006, doi: 10.1161/CIRCULATIONAHA.106.649244
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
114/19/2056    most recent
CIRCULATIONAHA.106.649244v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, Z.
Right arrow Articles by Linden, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, Z.
Right arrow Articles by Linden, J.
Related Collections
Right arrow Animal models of human disease
Right arrow Ischemic biology - basic studies
Right arrow Acute myocardial infarction

(Circulation. 2006;114:2056-2064.)
© 2006 American Heart Association, Inc.


Molecular Cardiology

Myocardial Infarct–Sparing Effect of Adenosine A2A Receptor Activation Is due to Its Action on CD4+ T Lymphocytes

Zequan Yang, MD, PhD; Yuan-Ji Day, MD, PhD; Marie-Claire Toufektsian, PhD; Yaqin Xu, MD, PhD; Susan I. Ramos, BS; Melissa A. Marshall, BS; Brent A. French, PhD; Joel Linden, PhD

From the Departments of Biomedical Engineering (Z.Y., M.-C.T., Y.X., B.A.F.), Medicine and Pharmacology (S.I.R., M.A.M., B.A.F., J.L.), and Surgery (Z.Y.), University of Virginia Health System, Charlottesville; and Department of Anesthesiology, Chang Gung University Hospital, Taipei, Taiwan (Y.-J.D.).

Correspondence to Dr Zequan Yang, Departments of Biomedical Engineering and Surgery, University of Virginia Health System, Box 800759, Charlottesville, VA 22903. E-mail zy6b{at}virginia.edu

Received July 1, 2006; revision received August 14, 2006; accepted September 1, 2006.

Background— We previously used adenosine A2A receptor (A2AR) knockout (KO) mice and bone marrow transplantation to show that the infarct-sparing effect of A2AR activation at reperfusion is primarily due to effects on bone marrow–derived cells. In this study we show that CD4+ but not CD8+ T lymphocytes contribute to myocardial ischemia/reperfusion injury.

Method and Results— After a 45-minute occlusion of the left anterior descending coronary artery and reperfusion, T cells accumulate in the infarct zone within 2 minutes. Addition of 10 µg/kg of the A2AR agonist ATL146e 5 minutes before reperfusion produces a significant reduction in T-cell accumulation and a significant reduction in infarct size (percentage of risk area) measured at 24 hours. In Rag1 KO mice lacking mature lymphocytes, infarct size is significantly smaller than in C57BL/6 mice. Infarct size in Rag1 KO mice is increased to the level of B6 mice by adoptive transfer of 50 million CD4+ T lymphocytes derived from C57BL/6 or A2AR KO but not interferon-{gamma} KO mice. ATL146e completely blocked the increase in infarct size in Rag1 KO mice reconstituted with B6 but not A2AR KO CD4+ T cells. The number of neutrophils in the reperfused heart at 24 hours after infarction correlated well with the number of lymphocytes and infarct size.

Conclusions— These results strongly suggest that the infarct-sparing effect of A2AR activation is primarily due to inhibition of CD4+ T-cell accumulation and activation in the reperfused heart.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
CirculationHome page
Y. Maekawa, N. Mizue, A. Chan, Y. Shi, Y. Liu, S. Dawood, M. Chen, F. Dawood, G. de Couto, G. H. Li, et al.
Survival and Cardiac Remodeling After Myocardial Infarction Are Critically Dependent on the Host Innate Immune Interleukin-1 Receptor-Associated Kinase-4 Signaling: A Regulator of Bone Marrow-Derived Dendritic Cells
Circulation, October 6, 2009; 120(14): 1401 - 1414.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. L. Lau, Y. Zhao, I. L. Kron, M. H. Stoler, V. E. Laubach, G. Ailawadi, and J. Linden
The Role of Adenosine A(2A) Receptor Signaling in Bronchiolitis Obliterans.
Ann. Thorac. Surg., October 1, 2009; 88(4): 1071 - 1078.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Z. Yang, A. K. Sharma, J. Linden, I. L. Kron, and V. E. Laubach
CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury.
J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 695 - 702.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Z. Yang, V. E. Laubach, B. A. French, and I. L. Kron
Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion.
J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 723 - 729.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. B. Ascon, M. Ascon, S. Satpute, S. Lopez-Briones, L. Racusen, R. B. Colvin, M. J. Soloski, and H. Rabb
Normal mouse kidneys contain activated and CD3+CD4-CD8- double-negative T lymphocytes with a distinct TCR repertoire
J. Leukoc. Biol., December 1, 2008; 84(6): 1400 - 1409.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Yang, J. Linden, S. S. Berr, I. L. Kron, G. A. Beller, and B. A. French
Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRI
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2328 - H2335.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. C. Lisle, L. M. Gazoni, L. G. Fernandez, A. K. Sharma, A. M. Bellizzi, G. D. Schifflett, V. E. Laubach, and I. L. Kron
Inflammatory lung injury after cardiopulmonary bypass is attenuated by adenosine A(2A) receptor activation.
J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1280 - 1288.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. H. Rork, K. L. Wallace, D. P. Kennedy, M. A. Marshall, A. R. Lankford, and J. Linden
Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1825 - H1833.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A Abbate, R Bussani, G Liuzzo, G G L Biondi-Zoccai, E Barresi, P Mellone, G Sinagra, A Dobrina, F De Giorgio, R Sharma, et al.
Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation
Heart, June 1, 2008; 94(6): 737 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Hasko and P. Pacher
A2A receptors in inflammation and injury: lessons learned from transgenic animals
J. Leukoc. Biol., March 1, 2008; 83(3): 447 - 455.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Durst, H. Danenberg, R. Gallily, R. Mechoulam, K. Meir, E. Grad, R. Beeri, T. Pugatsch, E. Tarsish, and C. Lotan
Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3602 - H3607.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Morrison, X. L. Tan, C. Ledent, S. J. Mustafa, and P. A. Hofmann
Targeted deletion of A2A adenosine receptors attenuates the protective effects of myocardial postconditioning
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2523 - H2529.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Frantz, J. Tillmanns, P. J. Kuhlencordt, I. Schmidt, A. Adamek, C. Dienesch, T. Thum, S. Gerondakis, G. Ertl, and J. Bauersachs
Tissue-Specific Effects of the Nuclear Factor {kappa}B Subunit p50 on Myocardial Ischemia-Reperfusion Injury
Am. J. Pathol., August 1, 2007; 171(2): 507 - 512.
[Abstract] [Full Text] [PDF]